Journal article
Comparison of conservative management techniques in the re-treatment of ipsilateral breast tumor recurrence
Brachytherapy, v 10(1)
2011
PMID: 20685174
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
To compare brachytherapy and three-dimensional (3-D) conformal external beam radiotherapy for breast cancer presenting in the previously irradiated breast.
Thirty-six patients with TIS–T2 breast carcinomas received brachytherapy or 3-D conformal radiotherapy (3-D CRT) after lumpectomy in a previously irradiated breast as an alternative to salvage mastectomy. Brachytherapy consisted of low-dose-rate (LDR) interstitial technique in 21 patients, whereas 11 patients were treated using high-dose-rate (HDR) balloon technique. Four patients received 3-D CRT. Cosmesis was graded according to the Harvard criteria and the Allegheny General Modification of the Harvard criteria. Acute sequelae were graded according to the Common Terminology Criteria for Adverse Events (version 3.0).
Thirty-five of 36 patients remained free of local failure, with a mean followup of 37 months. Five patients treated with LDR developed Grade II and two developed Grade III acute side effects. No patient treated with balloon brachytherapy or 3-D CRT developed a Grade II or higher acute effect. Cosmetically, 12 LDR interstitial patients were scored as Grade I, six as Grade II, and three as Grade III. Nine of the HDR patients were scored as Grade I, one as Grade II, and one as Grade III. Two 3-D CRT patients were scored as Grade II and two as Grade III. The Allegheny Modification of the Harvard criteria more accurately reflected the cosmetic effects of re-treatment.
Brachytherapy is feasible for patients who desire breast preservation in a previously irradiated breast. All techniques demonstrated similar local control rates. Acute side effects were less, and cosmesis was superior in HDR balloon brachytherapy.
Metrics
Details
- Title
- Comparison of conservative management techniques in the re-treatment of ipsilateral breast tumor recurrence
- Creators
- Mark Trombetta - Allegheny General HospitalThomas B. Julian - Allegheny General HospitalE. Day Werts - Allegheny General HospitalAthanasios Colonias - Allegheny General HospitalJames Betler - Department of Radiation Oncology Allegheny General Hospital Pittsburgh PAKatherine Kotinsley - Department of Radiation Oncology Allegheny General Hospital Pittsburgh PAYongbok Kim - Drexel UniversityDavid Parda - Allegheny General Hospital
- Publication Details
- Brachytherapy, v 10(1)
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine); Radiology (Radiologic Sciences)
- Web of Science ID
- WOS:000287003000015
- Scopus ID
- 2-s2.0-78651438936
- Other Identifier
- 991019167560504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging